Trial Profile
PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE +/- TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER. [Trattamento preoperatorio con letrozolo ± Triptorelin nel carcinoma mammario localmente avanzato endocrinoresponsivo ER e PgR greater than 50 %]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2013
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Triptorelin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Aug 2011 New trial record